missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Temozolomide Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR14371G
Description
Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to pharmacopeia primary standards.Temozolomide is an alkylating agent of the imidazotetrazine group. It is a chemotherapy drug, used in the treatment of anaplastic astrocytoma, glioblastoma multiforme and malignant metastatic melanoma, which works by arresting cancer cell growth.Specifications
| 85622-93-1 | |
| C6H6N6O2 | |
| Temozolomide; 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide; 3-Methyl-4-oxo-8-imidazolo[5,1-d][1,2,3,5 ]tetrazinecarboxamide; 4-Methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0 ]nona-2,7,9-triene-9-carboxamide; 8-Carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one; NSC 362856 | |
| 1 g | |
| Certified Reference Material |
| These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. | |
| MFCD00866492 | |
| Certified Reference Material | |
| 194.15 |